Nordea Investment Management Ab Ionis Pharmaceuticals Inc Transaction History

Nordea Investment Management Ab

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$34.54 - $47.25 $178,088 - $243,621	-5,156 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$47.45 - $62.95 $244,652 - $324,570	-5,156 Reduced 50.0%	5,156 $252,000
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $241,558 - $314,773	5,156 Added 100.0%	10,312 $607,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $5.84 Million - $8.1 Million	-94,032 Reduced 94.8%	5,156 $332,000
Q1 2019 May 20, 2019	SELL	$52.92 - $81.17 $165,216 - $253,412	-3,122 Reduced 3.05%	99,188 $8.05 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $159,037 - $218,333	-3,667 Reduced 3.46%	102,310 $5.53 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $1.66 Million - $2.08 Million	38,663 Added 57.44%	105,977 $5.47 Million
Q2 2018 Aug 13, 2018	BUY	$40.53 - $50.7 $306,163 - $382,987	7,554 Added 12.64%	67,314 $2.81 Million
Q1 2018 May 14, 2018	BUY	$44.08 - $55.05 $2.63 Million - $3.29 Million	59,760 New	59,760 $2.63 Million

414

136M

862K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.63B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.